Increased risk of venous thromboembolism (VTE) and shorter survival in neuroendocrine versus castration-resistant prostate cancer

被引：0
|
作者：
Jakubowski, C. [1 ]
Vlachostergios, P. J. [1 ]
Christos, P. [2 ]
Nanus, D. M. [1 ,3 ]
Beltran, H. [1 ,3 ]
Tagawa, S. T. [1 ,3 ]
机构：
[1] Weill Cornell Med, Div Hematol & Med Oncol, New York, NY USA
[2] Weill Cornell Med, Div Biostat & Epidemiol, New York, NY USA
[3] Weill Cornell Med, Meyer Canc Ctr, New York, NY USA
来源：
THROMBOSIS RESEARCH | 2018年 / 164卷
关键词：
D O I：
10.1016/j.thromres.2018.02.074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-34
引用
收藏
页码：S214 / S214
页数：1
相关论文
共 50 条
  • [1] Risk of venous thromboembolism, survival, and expression of procoagulant genes in neuroendocrine versus castration-resistant prostate cancer.
    Vlachostergios, Panagiotis J.
    Jakubowski, Christopher D.
    Lam, Linda
    Christos, Paul J.
    Nanus, David M.
    Sboner, Andrea
    Khani, Francesca
    Beltran, Himisha
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Association of plasma tumor DNA (ptDNA) with increased risk of venous thromboembolism (VTE) in metastatic castration resistant prostate cancer patients (mCRPC).
    Conteduca, Vincenza
    Scarpi, Emanuela
    Wetterskog, Daniel
    Ferroni, Fabio
    Rossi, Alice
    Romanel, Alessandro
    Gurioli, Giorgia
    Bleve, Sara
    Gianni, Caterina
    Brighi, Nicole
    Schepisi, Giuseppe
    Lolli, Cristian
    Cortesi, Pietro
    Barone, Domenico
    Demichelis, Francesca
    Paganelli, Giovanni
    Beltran, Himisha
    Attard, Gerhardt
    De Giorgi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients
    Conteduca, Vincenza
    Scarpi, Emanuela
    Wetterskog, Daniel
    Brighi, Nicole
    Ferroni, Fabio
    Rossi, Alice
    Romanel, Alessandro
    Gurioli, Giorgia
    Bleve, Sara
    Gianni, Caterina
    Schepisi, Giuseppe
    Lolli, Cristian
    Cortesi, Pietro
    Matteucci, Federica
    Barone, Domenico
    Paganelli, Giovanni
    Demichelis, Francesca
    Beltran, Himisha
    Attard, Gerhardt
    De Giorgi, Ugo
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (07) : 1166 - 1173
  • [4] Bevacizumab (BEV) and risk of arterial (ATE) and venous thromboembolism (VTE) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401(ALLIANCE)
    Patel, Jai N.
    Jiang, Chen
    Hertz, Daniel L.
    Mulkey, Flora A.
    Friedman, Paula N.
    Halabi, Susan
    Ratain, Mark J.
    Morris, Michael J.
    Small, Eric J.
    Owzar, Kouros
    Kelly, William K.
    McLeod, Howard L.
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer
    Nordin, Anna
    Wang, Wanzhong
    Welen, Karin
    Damber, Jan-Erik
    PROSTATE, 2013, 73 (06) : 657 - 667
  • [6] Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
    Hussain, Maha
    Mateo, Joaquin
    Fizazi, Karim
    Saad, Fred
    Shore, Neal
    Sandhu, Shahneen
    Chi, Kim N.
    Sartor, Oliver
    Agarwal, Neeraj
    Olmos, David
    Thiery-Vuillemin, Antoine
    Twardowski, Przemyslaw
    Roubaud, Guilhem
    Ozguroglu, Mustafa
    Kang, Jinyu
    Burgents, Joseph
    Gresty, Christopher
    Corcoran, Claire
    Adelman, Carrie A.
    de Bono, Johann
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (24) : 2345 - 2357
  • [7] Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
    Beltran, Himisha
    Prandi, Davide
    Mosquera, Juan Miguel
    Benelli, Matteo
    Puca, Loredana
    Cyrta, Joanna
    Marotz, Clarisse
    Giannopoulou, Eugenia
    Chakravarthi, Balabhadrapatruni V. S. K.
    Varambally, Sooryanarayana
    Tomlins, Scott A.
    Nanus, David M.
    Tagawa, Scott T.
    Van Allen, Eliezer M.
    Elemento, Olivier
    Sboner, Andrea
    Garraway, Levi A.
    Rubin, Mark A.
    Demichelis, Francesca
    NATURE MEDICINE, 2016, 22 (03) : 298 - 305
  • [8] Neuroendocrine differentiation in castration-resistant prostate cancer: A case report
    Priftakis, Dimitrios
    Kritikos, Nikolaos
    Stavrinides, Stavros
    Kleanthous, Stefanos
    Baziotis, Nikolaos
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (06) : 1392 - 1394
  • [9] Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
    Himisha Beltran
    Davide Prandi
    Juan Miguel Mosquera
    Matteo Benelli
    Loredana Puca
    Joanna Cyrta
    Clarisse Marotz
    Eugenia Giannopoulou
    Balabhadrapatruni V S K Chakravarthi
    Sooryanarayana Varambally
    Scott A Tomlins
    David M Nanus
    Scott T Tagawa
    Eliezer M Van Allen
    Olivier Elemento
    Andrea Sboner
    Levi A Garraway
    Mark A Rubin
    Francesca Demichelis
    Nature Medicine, 2016, 22 : 298 - 305
  • [10] Toward Predictors of Survival in Castration-Resistant Prostate Cancer
    Graff, Julie N.
    Beer, Tomasz M.
    CANCER, 2011, 117 (17) : 3882 - 3884
12345